DAEWOONG PHARMACEUTICAL CO.LTD.
Daewoong
Global Healthcare Group
The Best Partner for You
Global Healthcare Group
The Best Partner for You
Plants
Pan-Global Specialized Manufacturing Capabilities
Korea Plants
Daewoong Pharmaceutical has a number of
strategically located manufacturing sites, each of
which specializes in various production lines
such as depot, liquid suspension, biologics, and etc.
strategically located manufacturing sites, each of
which specializes in various production lines
such as depot, liquid suspension, biologics, and etc.
Osong Plant
Chungcheongbuk-do, South Korea- Feature
- Highly automated mass production facility
-
Qualified injection manufacturing facility
- Capacity: Dual Chamber Syringe (0.35M), Prefilled
Syringe (0.25M), Tablet (2B)
- Area
- 40,892 m2 (440,158 ft2)
- Manufacturing Products
- Oral Solid, Depot Injection, Vial, Ampoule
Hyangnam
Plant
Hyangnam, South Korea
- Feature
- Main manufacturing site for oral solids,
suspensions, injectables and biologics - Produces Korea’s first new biomedicine ‘EGF’
(Epidermal Growth Factor) - Supports clinical trial(phase 1-3) batch sizes
and clinical scale-up manufacturing - Capacity: Tablet (1B), Prefilled Syringe (1M)
- Area
- 31,735 m2 (341,598 ft2)
- Manufacturing Products
- Oral Solid, Microbial Product,
Cell cultured Product
Seongnam
Daewoong-Bio
Plant
Seongnam, South Korea
- Feature
- Top cephalosporin CMO facility
- RABS (Restricted-access barrier system) ensures
sterility and validated aseptic-quality products - Capacity: Powder Injection Filling Line (24M Vial),
Tablet (100M), Capsule (100M)
- Area
- 7,535 m2 (81,106 ft2)
- Manufacturing Products
- Cephalosporin Injection, Tablet, Capsule
Anseong
Daewoong-Bio
Plant
Anseong, South Korea
- Area
- 8,180 m2 (88,048 ft2)
- Manufacturing Products
- Oral Solid
Daejeon Plant(HANALL BIOPHARMA)
Daejeon, South Korea- Area
- 9,011 m2 (96,993 ft2)
- Manufacturing Products
- A/A infusion, Oral Solid